98%
921
2 minutes
20
Introduction: The association between the visceral adiposity index (VAI) and cognitive function in middle-aged and older Chinese adults is not well understood. The "obesity paradox"-where obesity appears to be linked with better health outcomes-has also been observed. This study aims to clarify the association by using data from a nationally representative longitudinal survey.
Methods: This study analyzed five waves of data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2020. The Cox proportional hazards regression model was used to assess the effect of VAI on the occurrence of cognitive impairment. Additionally, cognitive trajectories over the study period were identified using group-based trajectory modeling (GBTM), and the association between VAI and cognitive trajectories was further analyzed through multinomial logistic regression.
Results: A total of 5,637 participants aged ≥45 years were included, of whom 46.6% were women. The risk of cognitive impairment was lower in participants with higher VAI scores (Q3: HR = 0.79, 95% CI: 0.67-0.94; Q4: HR = 0.83, 95% CI: 0.70-0.98). Cognitive trajectories over the 9-year period were categorized into four groups based on cognitive Z-scores: "high and stable" ( = 621, 12.6%), "middle and stable" ( = 2,157, 36.7%), "low and stable" ( = 1,856, 32.8%), and "low and decline" ( = 1,003, 17.9%). After adjusting for demographic and health-related variables, participants in the highest VAI quartile (Q4) had a significantly lower likelihood of experiencing cognitive decline (adjusted OR = 0.67, 95% CI: 0.48-0.93).
Conclusion: Greater visceral adiposity was associated with a lower risk of developing cognitive impairment and a more favorable cognitive trajectory over time.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12354607 | PMC |
http://dx.doi.org/10.3389/fpubh.2025.1612801 | DOI Listing |
J Alzheimers Dis
September 2025
Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Università Campus Bio-Medico di Roma, Roma, Italy.
BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder. While AD diagnosis traditionally relies on clinical criteria, recent trends favor a precise biological definition. Existing biomarkers efficiently detect AD pathology but inadequately reflect the extent of cognitive impairment or disease heterogeneity.
View Article and Find Full Text PDFJ Alzheimers Dis
September 2025
Paula Costa-Urrutia Medical Affairs, Terumo BCT, Edificio Think MVD, Montevideo, Uruguay.
BackgroundTherapeutic plasma exchange (TPE) with albumin replacement has emerged as a potential treatment for Alzheimer's disease (AD). The AMBAR trial showed that TPE could slow cognitive and functional decline, along with changes in core and inflammatory biomarkers in cerebrospinal fluid.ObjectiveTo evaluate the safety and effectiveness of TPE in a real-world setting in Argentina.
View Article and Find Full Text PDFEndocrine
September 2025
Department of General Medicine, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India.
Metab Brain Dis
September 2025
Department of Neuroscience, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Brain ischemia is a major global cause of disability, frequently leading to psychoneurological issues. This study investigates the effects of 4-aminopyridine (4-AP) on anxiety, cognitive impairment, and potential underlying mechanisms in a mouse model of medial prefrontal cortex (mPFC) ischemia. Mice with mPFC ischemia were treated with normal saline (NS) or different doses of 4-AP (250, 500, and 1000 µg/kg) for 14 consecutive days.
View Article and Find Full Text PDFEur Geriatr Med
September 2025
School of Public Health Sciences, University of Waterloo, Waterloo, Canada.
Purpose: Sleep disturbance is prevalent in long-term care facilities (LTCFs), yet there is limited understanding of individual factors predicting changes in sleep within these populations. Our objective was to determine predictors of sleep disturbance in LTCFs and investigate variation in prevalence across facilities in two Canadian provinces-New Brunswick and Saskatchewan.
Method: This retrospective longitudinal cohort study used interRAI comprehensive health assessment data from 2016 to 2021, encompassing 21,394 older adults aged ≥ 65 years across 228 LTCFs.